- Home
- ENTX vs EBMT Comparison
ENTX vs EBMT Comparison
Compare ENTX & EBMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENTX | EBMT |
|---|---|---|
| Founded | 2010 | 1922 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.0M | 132.0M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ENTX | EBMT |
|---|---|---|
| Price | $1.71 | $20.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 219.0K | 38.0K |
| Earning Date | 11-14-2025 | 01-27-2026 |
| Dividend Yield | N/A | ★ 2.97% |
| EPS Growth | N/A | ★ 58.15 |
| EPS | N/A | ★ 1.72 |
| Revenue | $124,000.00 | ★ $87,531,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.26 |
| P/E Ratio | ★ N/A | $11.35 |
| Revenue Growth | ★ 25.25 | 9.36 |
| 52 Week Low | $1.50 | $14.35 |
| 52 Week High | $3.22 | $20.23 |
Technical Indicators
Market Signals| Indicator | ENTX | EBMT |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 70.33 |
| Support Level | $1.53 | $19.27 |
| Resistance Level | $1.99 | $20.23 |
| Average True Range (ATR) | 0.19 | 0.55 |
| MACD | -0.00 | -0.09 |
| Stochastic Oscillator | 32.73 | 89.88 |
Price Performance
Historical ComparisonAbout ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.